Atlas FDA

DAKOCYTOMATION EGFR PHARMDX KIT

FDA premarket approval P030044/S001 · decided 2006-02-01

Approval details

PMA number
P030044
Supplement
S001
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
DAKOCYTOMATION EGFR PHARMDX KIT
Generic name
Immunohistochemistry assay, antibody, epidermal growth factor receptor
Applicant
Agilent Technologies, Inc.
Date received
2005-11-17
Decision date
2006-02-01
Days to decision
76 days
Decision code
APPR
Product code
NQF
Advisory committee
Pathology
Expedited review
No
Location
Santa Clara, CA
Statement
APPROVAL FOR ADDITIONAL LABELING CHANGES INCLUDE A CLARIFICATION IN THE DEFINITION OF POSITIVE STAINING FOR INDIVIDUAL TUMOR CELLS, INCLUSION OF LIMITATION ABOUT CETUXIMAB RESPONSE RATE FOR NEGATIVE/ POSITIVE PATIENTS AND PERFORMANCE INDICES FOR PATIENTS WHO HAD <1% POSITIVE TUMOR CELLS FOR EGFR.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GenetiSure Dx Postnatal Assay (K163367)Agilent Technologies, Inc.2017-08-11
MODIFICATION TO DEVICE LINK SYSTEM, MODEL M2376A (K012094)Agilent Technologies, Inc.2001-07-20
AGILENT M2636B TELEMON B MONITOR (TELEMON B) (K011824)Agilent Technologies, Inc.2001-07-02
HEARTSTREAM XL DEFIBIBRILLATOR/MONITOR, MODEL M4735A, HEARTSTREAM XLT DEFIBRILLATOR/MONITOR.MODEL M2500B (K010634)Agilent Technologies, Inc.2001-06-11
M2376A DEVICELINK SYSTEM, MODEL M2376A (K011578)Agilent Technologies, Inc.2001-06-08
HEARTSTREAM ATTENUATED DEFIBRILLATION PADS, MODEL M3870A (K003819)Agilent Technologies, Inc.2001-05-02
AGILENT INFORMATION CENTER SOFTWARE FOR M3150,M3151,M3153 AND M3154 (K011093)Agilent Technologies, Inc.2001-05-01
M2376A DEVICELINK SYSTEM (K010453)Agilent Technologies, Inc.2001-03-02